The ALP “LipoVeson™” Protocol (formerly NanoVeson) is based on a novel method to remodel lipid membranes. LipoVeson triggers compound release and capture for removal. The implications for human health are significant. The objective is to reduce inflammatory lipids (and other compounds) in membranes and cells for prevention, treatment, and diagnostics.

The ALP LipoVeson™ protocol research continues. Stay tuned...